Drugs made in America create jobs, drive prices down, and protect national security. Combined with recent advances in cancer treatment, the changes could ease one of the heaviest burdens facing Shasta County and North State families: the cost of staying alive and functioning. On August 31, President Trump announced agreements with nine additional pharmaceutical manufacturers under the Most-Favored-Nation (MFN) pricing initiative. Combined with earlier deals, 26 companies now